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AbsTrACT
Objective to determine if human colonic 
neuromuscular functions decline with increasing age.
Design looking for non-specific changes in 
neuromuscular function, a standard burst of electrical 
field stimulation (eFS) was used to evoke neuronally 
mediated (cholinergic/nitrergic) contractions/relaxations 
in ex vivomuscle strips of human ascending and 
descending colon, aged 35–91 years (macroscopically 
normal tissue; 239 patients undergoing cancer resection). 
then, to understand mechanisms of change, numbers 
and phenotype of myenteric neurons (30 306 neurons 
stained with different markers), densities of intramuscular 
nerve fibres (51 patients in total) and pathways involved 
in functional changes were systematically investigated 
(by immunohistochemistry and use of pharmacological 
tools) in elderly (≥70 years) and adult (35–60 years) 
groups.
results With increasing age, eFS was more likely to 
evoke muscle relaxation in ascending colon instead 
of contraction (linear regression: n=109, slope 
0.49%±0.21%/year, 95% ci), generally uninfluenced 
by comorbidity or use of medications. Similar changes 
were absent in descending colon. in the elderly, overall 
numbers of myenteric and neuronal nitric oxide synthase-
immunoreactive neurons and intramuscular nerve 
densities were unchanged in ascending and descending 
colon, compared with adults. in elderly ascending, not 
descending, colon numbers of cell bodies exhibiting 
choline acetyltransferase immunoreactivity increased 
compared with adults (5.0±0.6 vs 2.4±0.3 neurons/
mm myenteric plexus, p=0.04). cholinergically mediated 
contractions were smaller in elderly ascending colon 
compared with adults (2.1±0.4 and 4.1±1.1 g-tension/g-
tissue during eFS; n=25/14; p=0.04); there were no 
changes in nitrergic function or in ability of the muscle 
to contract/relax. Similar changes were absent in 
descending colon.
Conclusion in ascending not descending colon, ageing 
impairs cholinergic function.
INTrODuCTION
There is evidence that human GI functions change 
in the elderly (>65–70 years),1 contributing to 
the development of constipation with associ-
ated pain, loss of dignity, reduced quality of life, 
faecal impaction and incontinence.1 2 Approxi-
mately 30%–40% of people aged 65 years or older 
self-report constipation.3 However, other factors 
are important, including changes in diet, fluid 
intake, exercise, bowel disorders (eg, diverticulitis 
or bowel cancer) and use of medications that reduce 
significance of this study
What is already known on this subject?
 ► Studies in ageing rodents suggest loss of 
myenteric neurons and a decline in cholinergic 
function of the colon. However, not all studies 
agree and uncertainty exists in terms of how 
these findings translate to humans.
 ► Studies using human colon have generally 
used small numbers of tissues with variable or 
undefined clinical history and heterogeneous 
techniques, generating inconsistent data.
 ► Nevertheless, a decline in neuromuscular 
functions has been suggested to contribute 
to the mechanisms underlying the increased 
incidence of constipation among the elderly.
What are the new findings?
 ► In a large functional study (ascending/
descending colon from, respectively, 109 and 
130 patients), increasing age increased the 
likelihood that electrical nerve stimulation 
caused muscle relaxation in ascending colon, 
instead of contraction, but no age-related 
changes were observed in descending colon.
 ► The functional changes with increasing 
age were not explained by loss of neurons 
within the myenteric plexus, reduced density 
of intramuscular axon bundles or changes 
in numbers of nitrergic neurons, but were 
associated with an increase in choline 
acetyltransferase (ChAT) immuno-positive 
myenteric nerve cell bodies in ascending, not 
descending colon.
 ► Functional changes with increasing age were 
explained by a decline in cholinergic function 
in ascending but not in descending colon 
(allowing an unchanged nitrergic function to 
exert greater inhibitory influence on cholinergic 
activity).
 ► There were no regional or age-related 
differences in the ability of the smooth muscle 
to contract or relax.
 o
n
 19 Septem
ber 2018 by guest. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2018-316279 on 18 September 2018. Downloaded from 
2 Broad J, et al. Gut 2018;0:1–14. doi:10.1136/gutjnl-2018-316279
Neurogastroenterology
GI motility (eg, opioid-based analgesics, tricyclic antidepres-
sants, calcium-channel antagonists2 4).
In rodents, declining colonic neuromuscular functions are 
reported during increasing age; some5 6 (not all7) report reduced 
numbers of myenteric cholinergic neurons and glial cells, 
reduced mucosal secretory capacity and slower intestinal transit. 
However, caution is required when translating such data to 
humans. Rodents have high metabolic rates, relatively short life 
spans8 and GI physiology distinct from primates, with functional 
disparities reflected by differences in anatomy, neuronal func-
tions, receptor pharmacology and molecular structures.9 Further 
complications are caused by genetic variation between different 
strains of laboratory rodents,10 including differences in loss of 
myenteric nitrergic neurons during advanced age.11 Alternative 
use of baboons12 does not entirely remove translational uncer-
tainty (the colon has adapted to fruit and vegetable diets13) and 
regardless, these animals are not suitable for routine research. 
Functional studies in humans have generated contradictory find-
ings, perhaps due to small sample sizes with unclear medical 
history and heterogeneous experimental approaches.14–16
This study aimed to determine if age-associated changes in 
neuromuscular functions can be identified using ex vivo prepara-
tions of human ascending and descending colon and then deter-
mine mechanisms of change by multiple, systematic anatomical 
and pharmacological approaches.
MATerIAls AND MeThODs
Patients and tissues
After ethical approval (REC 10/H0703/71), written informed 
consent was obtained for use of macroscopically normal 
ascending and descending/sigmoid (referred to hereon as 
descending) colon (5–10 cm from tumour) from patients under-
going elective surgery for non-obstructing bowel cancer. Patient 
records were examined for ongoing medication and comorbidity; 
clinical investigations into bowel functions were not conducted. 
No patient had previous chemoradiotherapy or diagnosis of 
inflammatory bowel disease. Tissue was immersed into preoxy-
genated Krebs solution 60–120 min after surgery. When investi-
gating mechanisms, two discontinuous age groups were studied, 
either side of the overall median age of patients examined: adult 
(35–60 years) and elderly (≥70 years).
Anatomical studies
Histopathology
Full thickness tissues, orientated to demonstrate mucosal, 
submucosal, muscularis and serosal layers, ~1×1 cm, were fixed 
and embedded in paraffin blocks prior to cutting into multiple 
4 µm thick sections. Sections were stained with H&E for routine 
histopathological assessment. Significant inflammation was 
excluded by observation of crypt architecture, distortion and 
atrophy, lamina propria cellularity, basal plasmacytosis, active 
inflammation, granulomata, mucin depletion, crypt abscesses, 
cryptitis and ulceration.17
Myenteric neuronal quantitation
Neurons were immunostained using anti-human neuronal 
protein C/D (anti-HuC/D; pan-neuronal antigen for cytoplasmic 
RNA-binding proteins, labelling cell nucleus and perikaryon18), 
anti-choline acetyltransferase (anti-ChAT) and anti-neuronal 
nitric oxide synthase (anti-nNOS). For each, a median of seven 
sections were examined for each patient (so not less than 10 mm 
of stained myenteric plexus could be studied, usually more). 
Each section was cut from the same block (minimum 16 µm 
separation). Following antigen retrieval and visualisation, cell 
nuclei were counterstained with hematoxylin. Positive and 
negative controls were performed in colon (anti-Hu/C/D, anti-
nNOS) and spinal cord (anti-ChAT), with or without primary 
antibodies. Stained slides were scanned and digitally visualised.
For neuronal quantitation, a line was drawn along the 
myenteric plexus (freehand draw function in viewing software). 
For ganglion counts, sections stained with anti-HuC/D were 
viewed at ~40× magnification. To quantify cell bodies within 
each ganglion, sections stained with anti-HuC/D were viewed 
at 60×–80× magnification. Subclasses of myenteric cell bodies 
were counted separately after staining with anti-ChAT and anti-
nNOS. Counting of ganglia and cell bodies19 and other assess-
ments of staining were performed by two independent observers 
‘blinded’ to patient identity/age (online supplementary file 1).
Densitometric analysis of intramuscular nerve fibre bundles
Sections were labelled using anti-protein gene product 9.5 
(anti-PGP9.5) (online supplementary file 1) to examine changes 
in axons/nerve fibre bundles in the muscle. Stained slides were 
scanned, digitally visualised and two non-adjacent areas from 
each of three different regions investigated per section: circular 
Table 1 Patients and tissues used
region of colon
All tissues studied
Tissues used for 
functional studies Tissues used for h&e staining
n Age (years)
Gender 
(male:female) n (strips) Age (years) evidence of inflammation (ages) n
Ascending 113 69±1 (35–91) 0.7: 1 109 (1020) 67±3 (40–91) 4 (60, 73, 78, 78 years) 30
Descending/sigmoid 132 65±1 (35–91) 1.4: 1 130 (1276) 66±3 (35–91) 2 (60, 78 years) 28
n, number of patients (for functional studies, numbers of muscle strips used are given in parenthesis). The ages of the patients are given as mean±SEM with ranges in 
parenthesis. For functional studies, tissues were used after overnight storage in fresh Krebs solution at 4˚C (188 tissues), 44 on the day of surgery and 7 on the day of surgery and 
after storage.
how might it impact on clinical practice in the foreseeable 
future?
 ► The new findings indicate that absolute or selective neuronal 
loss is not likely in itself to be an important aetiological 
factor in lower GI symptoms associated with ageing.
 ► The detection of age-dependent changes in ascending but 
not descending colon (decreased cholinergic function and 
increased myenteric somal ChAT immunostaining) indicates 
that greater attention needs to be paid to region-dependent 
differences in how the human colon ages and in particular, 
the changes which occur within the cholinergic innervation.
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Figure 1 The effects of electrical field stimulation (EFS) in circular muscle of ascending and descending colon from adult (35 to 60 years) and 
elderly (≥70 years) patients. Panel A shows representative trace examples illustrating responses during and after termination of EFS over a range of 
frequencies of stimulation. EFS was applied at 1–20 Hz and at 50 V for 10 s every 1 min. Using tissues from the adult group, panel B shows the overall 
contraction force (mean±SEM g tension/g wet weight of tissue) generated during EFS in both regions of colon for each frequency of stimulation in the 
presence of vehicle, tetrodotoxin (TTX) 1 µM, atropine 1 µM or L-NAME (N
ω
-nitro-L-arginine methyl ester hydrochloride) 300 µM (n=5 each). Panels C 
and D show responses to EFS at 5 Hz, 50 V for 10 s, repeated every 1 min. The individual trace in panel C illustrates the ability of TTX 1 µM to inhibit 
responses evoked by repeated EFS. In panel D, the effects of single bursts of EFS are shown before and after treatment with atropine 1 µM or L-NAME 
300 µM, in two muscle strips cut from the same tissue (male, 74, descending colon). The 10 s period of EFS is indicated by the horizontal bars (note the 
expanded time scale relative to panel C). Atropine inhibited contractions during EFS and decreased after-contractions. L-NAME inhibited relaxations 
during EFS and facilitated contraction amplitudes.
 o
n
 19 Septem
ber 2018 by guest. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2018-316279 on 18 September 2018. Downloaded from 
4 Broad J, et al. Gut 2018;0:1–14. doi:10.1136/gutjnl-2018-316279
Neurogastroenterology
muscle near myenteric plexus, circular muscle close to the 
mucosa (deep circular muscle) and longitudinal muscle.
Cholinergic enzyme assays
ChAT, acetylcholinesterase (AChE) and butyrylcholinesterase 
(BChE) expression and activity in colon muscle were measured 
as previously described (online supplementary file 2).
Functional studies
Detailed methods have been described previously.20 21 In brief, 
after removing the mucosa, strips were cut parallel to the 
circular muscle (~5 mm wide, 10–15 mm long; 3–31 from each 
patient) and mounted in warmed tissue baths containing Krebs 
solution (mmol/L: NaCl 121.5, CaCl2 2.5, KH2PO4 1.2, KCl 
4.7, MgSO4 1.2, NaHCO3 25, glucose 5.6, equilibrated with 
5% CO2/95% O2) for measuring isometric muscle tension. After 
1-hour recovery, electrical field stimulation (EFS) was applied 
and consistent responses obtained.
Responses to EFS were analysed qualitatively by counting 
numbers of tissues relaxing or contracting. Quantitative 
measurements were of changes in tension/gram (g) wet weight of 
tissue; contractions were assigned positive values and relaxations 
negative values (if relaxation followed contraction, assignment 
was to the movement of greatest magnitude). Drug-induced 
changes were differences between the mean of three responses 
before and 30 min after drug application. In determining the 
effects of L-NAME (N
ω
-nitro-L-arginine methyl ester hydro-
chloride) and atropine (inhibiting, respectively, nitrergic and 
cholinergic functions in human colon20), one strip/patient was 
selected from multiple strips/patient exposed to these drugs for 
a number of different studies (computer random number gener-
ation). Similarly, when determining the influence of age on these 
responses, strips were randomly selected to match the propor-
tions of phenotype (contraction/relaxation in response to EFS) 
observed in each region of colon. Non-cumulative concentra-
tion– response curves for carbachol (muscarinic M1–M5 receptor 
agonist) and sodium nitroprusside (SNP; nitric oxide (NO) 
donor) were established by applying single concentrations for 
15 min or until maximum effect was observed (online supple-
mentary file 3 shows carbachol concentration–response curves).
Drugs were freshly prepared prior to use. Carbachol, atro-
pine, L-NAME , SNP and DEA-NO (diethylamine NONOate; 
diethylammonium (Z)−1-(N,N-diethylamino)diazen-1-ium-
1,2-diolate; Sigma, UK), MRS2500 (P2Y1 receptor antagonist 
in human colon22) and tetrodotoxin (TTX; Tocris, UK) were 
dissolved in distilled water. The L-type calcium channel stabiliser 
(S)-(-)-Bay K8644 was dissolved in dimethyl sulfoxide (DMSO) 
(Sigma) to 10 mM. A cocktail of neurokinin (NK)1, NK2 and 
NK3 receptor antagonists was prepared by dissolving L732138 
(Tocris) in DMSO, GR159897 (Tocris) and SB235375 (GSK) in 
ethanol, each to 10 mM, for use at, respectively, 1 µM, 0.1 µM 
and 0.1 µM bath concentrations, inhibiting tachykinergic func-
tions in human colon.20
statistical analysis
To test whether patient characteristics affected responses to EFS, 
measured initially when surveying the effects of age, contingency 
analyses (χ2 or Fisher’s exact test) were applied as a screening test 
to two groups (higher or lower than the mean percentage strip 
relaxation of adult ascending colon), with a conservative level 
of statistical significance used (p≤0.01) to allow for multiple 
comparisons. On the basis that only one of the 130 covariates 
evaluated appeared to confound results, multivariable analyses 
were not performed.
In mechanism-based functional experiments, EC50 and Emax 
values were obtained from three-parameter agonist–response 
curves using GraphPad Prism 7.02. Data are expressed as 
means±SEM. The n values represent number of patients. Differ-
ences between means were determined using analyses of variance 
(ANOVAs) with Sidak’s multiple comparisons test for unpaired 
observations. P value <0.05 represented statistical significance.
For anatomical studies, numbers of cell bodies were expressed 
per millimetre of myenteric plexus. Inter-rater differences 
(95% CI) were analysed using one-sample Student’s t-tests 
and proportional biases investigated using Bland-Altman plots 
(online supplementary file 1). For comparisons, normality 
testing (D’Agostino & Pearson) was performed and neurons/
mm length analysed for differences in means using ANOVAs 
with Sidak’s multiple comparisons test (11/12 variables were 
normally distributed). P value<0.05 represented statistical 
significance.
resulTs
Patients
Two hundred and forty-five patients (122 women; mean age 66 
(range 35–91) years) consented to provide fresh surgical colon 
(table 1). On H&E staining, only a minority of adult and elderly 
patients showed low-grade inflammation limited to the mucosa.
Table 2 Pharmacology of responses to EFS in circular muscle from human adult ascending and descending colon
Drug response
Adult ascending Adult descending
During eFs
(g/g tension)
After eFs
(g/g tension)
During eFs
(g/g tension)
After eFs
(g/g tension)
Atropine
1 µM
Contraction prevented during EFS, revealing or enhancing 
relaxation; contractions after EFS attenuated
−2.6±1.0 (6) −1.8±0.8 (4) −1.7±0.6 (8) −1.8±0.5 (8)
Atropine plus NK1–3 
antagonists
As above but with consistent inhibition of contractions 
after EFS
−4.4±2.1 (5) −1.5±0.5 (3) −0.7±0.4 (4) −4.1±1.9 (3)
L-NAME
300 µM
Contraction during EFS increased in ascending colon only; 
no consistent effect on contractions after EFS
3.2±1.1 (14) −0.2±1.2 (7) 0.8±0.5 (16) 0.8±0.7(14)
MRS2500
1 µM
No consistent change during and after EFS 0.8±0.5 (5) 0.1±0.3 (3) 0.3±0.1 (4) −2.3±1.0 (3)
EFS was applied at 5 Hz, 50 V for 10 s, repeated every 1 min. The effects of treatment with atropine, NK1,2,3 receptor antagonists (L732138 1 µM, GR 159897 0.1 µM and SB-
235375 0.1 µM, applied together and in the presence of atropine), L-NAME and MRS2500 are shown for the responses during and after EFS. Data are given as the decrease or 
increase in mean±SEM of the overall muscle tension during each phase of EFS, expressed as g tension/g wet weight of tissue. The n values (in parenthesis) refer to numbers of 
patients; since after-contractions were not consistently observed in tissues from all patients, these were sometimes smaller.
EFS, electrical field stimulation; L-NAME, N
ω
-nitro-L-arginine methyl ester hydrochloride.
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Age-related changes in overall function
Before examining mechanisms of change we looked for exis-
tence of any non-specific change in neuromuscular function, 
using a standard burst of EFS to evoke neuronally mediated 
contractions/relaxations in muscle strips from large numbers of 
human ascending and descending colon over a wide age range 
(35–91 years).
Preliminary experiments
To determine the optimal frequency to study, frequency–response 
curves were constructed using adult (n=34) and elderly (n=58) 
tissues (females and males assessed together). In adult ascending/
descending colon, 1–20 Hz EFS usually caused contraction often 
followed by after-contraction on termination of EFS (figure 1A). 
TTX 1 μM prevented responses to 1–5 Hz EFS, but small mono-
phasic contractions remained at higher frequencies (figure 1B). 
L-NAME 300 µM prevented any relaxations and increased the 
amplitude of contractions during EFS. Atropine 1 µM prevented 
contractions during EFS, revealing small muscle relaxations, 
particularly in ascending colon (figure 1B). Compared with 
adults, ascending colon from the elderly exhibited little-or-no 
muscle movement during 1–2 Hz EFS and contractions during 
5–20 Hz appeared smaller (respectively n=19, 32; there were 
no age-dependent differences in after-contractions), whereas in 
descending colon from the elderly, any effects of increasing age 
were unclear (n=12–26; online supplementary file 4).
These small numbers of patients precluded meaningful statis-
tical analyses. However, they supported initiation of a larger 
Figure 2 Age-dependent changes in phenotype of response to electrical field stimulation (EFS) in human ascending but not descending colon. For 
each patient (n=239), a mean of 10 strips (range 3–31) were examined and the number which relaxed or contracted during EFS expressed as the 
percentage of total tested for that patient. Panel A shows the percent values for relaxation during EFS in ascending colon from all patients. The linear 
regression line (95% confidence bands as dotted lines) demonstrates an increased likelihood of relaxation as age increases (slope=0.49%±0.21%/ 
year, n=109). Panel B shows no age-related changes in the percentage values for relaxation during EFS in descending colon (all patients: 
slope=0.09%±0.17%/year, n=130). Panel C shows the overall percentage of strips relaxing during EFS for each of the tissues studied and the 
percentage that contract after EFS, placed in the adult (35–60 years old; □) and elderly (≥70 years old; ■) age groups. For ascending colon, n=31 and 
58 and for descending colon, n=45 and 46. The data are given as means (±SEM). These were analysed using analysis of variance with Sidak’s multiple 
comparison tests; *p<0.05. For comparison between adult ascending and descending colon contraction after EFS, p=0.06, all other comparisons 
between adult groups, and adult and elderly groups were not statistically significant (p>0.70).
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investigation in which EFS was applied at the single frequency 
of 5 Hz, evoking a robust, TTX (1 µM)-sensitive muscle contrac-
tion or relaxation, usually followed by a large after-contraction 
(figure 1D). It was confirmed that atropine 1 µM and L-NAME 
300 µM prevented, respectively, contractions and relaxations 
during EFS, enhancing the opposing response (figure 1D, 
table 2). Atropine also reduced the amplitude of any after-con-
tractions, reduced further by NK1,2,3 receptor antagonism; 
MRS2500 1 µM had no consistent effects (table 2).
Age-dependent changes in neuromuscular responses
During EFS at 5 Hz, the occurrence of contractions or relax-
ations sometimes varied among different muscle strips from the 
same colon (figure 1D). To investigate the effects of advancing 
age, a mean of 10 strips (3–31 from each patient, depending on 
tissue availability) were examined (239 patients). The numbers 
of strips relaxing or contracting during EFS, and contracting 
after EFS, were expressed as the percentage total for that patient 
(note: the number of strips used from each region of colon was 
similar and showed no age-dependent selection bias; data not 
shown).
Advancing age (35 to 91 years) increased the likelihood that 
muscle relaxation, rather than contraction, occurred during 
EFS in ascending colon (figure 2A,C). In descending colon, 
there were no age-related changes in responses evoked during 
EFS (figure 2B,C) and the incidence of after-contractions was 
unchanged in either region of colon (figure 2C).
Multivariate logistic regression showed these results were 
largely uninfluenced by clinical variables with known potential 
to affect colon functions (table 3, online supplementary file 5) 
although use of α-adrenoceptor antagonists appeared associated 
with reduced occurrence of muscle relaxation during EFS.
Subsequent studies to examine mechanisms of change were 
conducted using two discontinuous age groups (35–60 and ≥70 
years), either side of the median age.
Mechanisms: anatomical
Myenteric neuronal cell bodies staining for nNOS and ChAT
In 36 patients (8 adult, 9 elderly ascending; 9/10 adult/
elderly descending), a mean of 36 mm of myenteric plexus/
antibody/ patient was sampled and 30 306 myenteric neurons 
counted (646 sections). 18 838 neurons were stained for HuC/D 
(3520/3104 adult/elderly ascending, 6580/5634 descending), 
ChAT (5047 neurons, respectively, 827/1153 and 1711/1356) 
and nNOS (6421 neurons, respectively, 1627/1235 and 
1743/1816). Reported changes were not influenced by interob-
server differences (online supplementary file 1).
Figure 3A shows examples of labelled sections; table 4 provides 
a summary. In adults, there appeared to be fewer myenteric ganglia 
and a smaller number of nerve cell bodies (corresponding to a 
smaller number of ChAT-staining cells) in ascending, relative to 
descending colon (respectively, n=8, 9 patients); these numbers 
did not change with increasing age (figure 3B; respectively, n=9, 
10). Compared with other antibodies, the signal-to-background 
Table 3 Contingency analyses to identify effect of patient state and trait variables on responses evoked by 5 Hz EFS in the ascending colon 
(n=109)
Variables
Muscle relaxation
P valueNo (n=49) Yes (n=60)
Medications
  Regular laxative use 3 (6.1%) 6 (10.0%) 0.51
  Opiates 7 (14.3%) 8 (13.3%) 0.89*
  NSAIDs 11 (22.4%) 13 (21.7%) 0.92*
  Anticholinergic drugs† 5 (10.2%)* 11 (18.3%) 0.28
  Calcium channel blocker 8 (16.3%) 13 (21.7%) 0.48*
  Diuretics 13 (26.5%) 13 (21.7%) 0.55*
  Beta blocker 9 (18.4%) 11 (18.3%) 1.00*
  Anti-arrhythmics 0 1 (1.7%) 1.00
  Inhalers 1 (2.0%) 8 (13.3%) 0.04
  5-alpha reductase inhibitor 3 (6.1%) 0 0.09
  Cation-containing agents 11 (22.4%) 16 (26.7%) 0.61*
  Bisphosphonates 2 (4.1%) 4 (6.7%) 0.69
  Anticonvulsants 0 1 (1.7%) 1.00
  Alpha blockers‡ 10 (20.4%) 2 (3.3%) 0.01
Medical history
  Diverticular disease 1 (2.0%) 5 (8.3%) 0.22
  Previous abdominal or pelvic surgery 12 (24.5%) 14 (23.3%) 0.89*
  Conditions affecting central nervous system 7 (14.3%) 10 (16.7%) 0.73*
  Psychiatric conditions 6 (12.2%) 4 (6.7%) 0.34
  Diabetes mellitus 10 (20.4%) 9 (15.0%) 0.46*
  Any thyroid conditions 2 (4.1%) 5 (8.3%) 0.46
  Cardiovascular conditions 12 (24.5%) 14 (23.3%) 0.89*
The table shows the numbers of patients (with percentage of total) with each factor. 
*Contingency comparisons are shown using Fisher’s exact test or χ2 test (due to multiple comparisons, p≤0.01 considered statistically significant).
†Medications from different category but with similar action on certain receptor type.
‡Includes those used for cardiovascular and urinary indications.
EFS, electrical field stimulation; NSAIDs, non-steroidal anti-inflammatory drugs. 
 o
n
 19 Septem
ber 2018 by guest. Protected by copyright.
http://gut.bmj.com/
G
ut: first published as 10.1136/gutjnl-2018-316279 on 18 September 2018. Downloaded from 
7Broad J, et al. Gut 2018;0:1–14. doi:10.1136/gutjnl-2018-316279
Neurogastroenterology
Figure 3 Expression of myenteric neuronal markers in ascending and descending colon. Panel A shows representative staining examples from 
the adult (35–60 years of age) and elderly group (≥70 years) for each region of colon, using antibodies for human neuronal protein C/D (HuC/D), 
choline acetyltransferase (ChAT) and neuronal nitric oxide synthase  (nNOS). Images were captured using NDP View version 2.3.1. Black scale bar is 
250 µm. Counting was performed by two independent observers, and the values for each tissue are the mean of these counts. A ganglion was defined 
as a neural structure containing at least two neurons. The areas counted as neurons were between the circular and longitudinal muscle layers and 
represented areas of dark brown perikaryal staining in a cell that contained a nucleus (granular stain must cover the nucleus OR encircle at least 50% 
of circumference of the nucleus AND at least some cytoplasmic granular brown staining must be present). If the staining overlapped or appeared as a 
continuous area of dark brown staining, in the presence of two distinct nuclei and cell membranes, this was counted as two cell bodies; if there was 
ambiguity about the presence of a nucleus, the cell was not included. Panel B shows the number of ganglia and number of neuron cell bodies per 
millimetre of myenteric plexus (using the pan-neuronal cell body marker HuC/D) for adult (□) and elderly (■) ascending and descending (respectively 
o and •) colon. Panel C is arranged similarly and shows the numbers of neuron cell bodies per millimeter of myenteric plexus stained by the antibody 
for ChAT or nNOS. In Panels B and C, the data are expressed as means±SEM; n=8 adult ascending, 9 elderly ascending, 9 adult descending and 10 
elderly descending colons for each stain. These were analysed using analysis of variance with Sidak’s multiple comparison tests; *P<0.05; **P<0.01, 
only where indicated. PGP9.5, protein gene product 9.5.
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differentiation for anti-ChAT was less strong. Nevertheless, 
in the elderly, the numbers of ChAT-immunolabelled neurons 
were consistently and significantly greater in ascending colon 
(figure 3C) but unchanged in descending colon. There were 
no statistically significant age-related differences in numbers of 
neurons expressing nNOS for either region (figure 3C). Post hoc 
calculation of statistical power (Stata SE v14.0) for the observed 
difference in ChAT immunostaining between adult and elderly 
ascending colon was 0.97 (expressed alternatively, only five 
patients would be required in each group to detect the observed 
difference with a power of 0.8). For the observed difference in 
HuC/D staining between ascending and descending colon, the 
post hoc power was 0.82.
Densitometric analysis of intramuscular nerve fibre bundles
In adults, the density of anti-PGP9.5 immunostaining within 
muscle was generally greater in descending, compared with 
ascending colon (figure 4B). In ascending colon of the elderly, 
the density of anti-PGP9.5 staining was unchanged compared 
with the adults. In descending colon of the elderly, the density 
was reduced only in deep circular muscle (figure 4B).
Cholinergic enzymes
In ascending colon there were no age-dependent differences 
in expression, specific activity or overall function of ChAT, 
although in descending colon ChAT function was greater in 
the elderly (expression unchanged), tending to increase specific 
activity (table 5). There were no age-dependent differences in 
AChE or BChE function in either region of colon (table 5).
Mechanisms: functional
Age-dependent/region-dependent reduction in cholinergic, not 
nitrergic functions
In ascending colon of both age groups, L-NAME 300 µM 
increased the magnitude of cholinergically mediated contractions 
during EFS, but this was barely evident in descending colon; 
after-contractions were not significantly changed (figure 5 shows 
the magnitude of response; online supplementary file 6 shows 
percentage change). However, in ascending colon from the 
elderly, the increase in contractions was smaller compared with 
the adults (p<0.05; figure 5C; ascending colon from, respec-
tively, n=14/25 adult/elderly patients; descending colon from 
16/23 adult/elderly).
Atropine 1 µM revealed or enhanced nitrergically mediated 
muscle relaxation and decreased the magnitude of after-con-
tractions (figure 5D). Comparing the age groups, there were no 
statistically significant differences in magnitudes of muscle relax-
ations or after-contractions evoked by EFS during the presence 
of atropine, in either region of colon (figure 5F; ascending colon 
from, respectively, n=6/6 adult/elderly and descending colon 
from 8/5 adult/elderly).
No age-dependent changes in muscle function
Advancing age did not influence contractions evoked by 
carbachol or Bay-K8644 in either region of colon (carbachol: 
respectively, n=7/7 and 8/12 ascending/descending colon from 
adult and elderly; Bay-K8644: n=5 each), nor relaxations 
evoked by SNP (table 6).
DIsCussION
This is the first large-scale study into the effects of advancing 
age on both neuromuscular anatomy and functions in human 
colon. It identified an age-dependent decline in cholinergic, not 
nitrergic, function but surprisingly, only in ascending colon. 
Paradoxically, the numbers of myenteric neurons staining posi-
tively for anti-ChAT increased in the same region, but there was 
no overall change in neuron count between adult and elderly 
patients.
The study was needed because human colon has important 
differences in anatomy and functions compared with mammals 
in which age research is usually conducted.13 23 Further, in those 
age-related studies undertaken using human colon, data are 
inconsistent.14–16 This may be because small numbers were used, 
insufficient to overcome genetic differences and human variation 
(especially among the elderly, with longer exposure to lifestyle 
factors affecting bowel function). Inconsistencies are also created 
by studying only ascending or descending/sigmoid colon; each 
has different primary functions (respectively, fermentation of 
unabsorbed polysaccharides with water/nutrient absorption and 
storage of faeces prior to defection), embryological origin and 
molecular profile.24 Finally, to draw appropriate conclusions, 
analysis of changes in both anatomy and functions is desirable. 
Thus, the high reserve capacity of the enteric nervous system 
(ENS) (in animals5) means that functions of the whole organ are 
not represented by investigations into only structure (eg, neuron 
numbers) or functions of individual cell types.
The study began with a simple, large-scale assessment of the 
overall neuromuscular functions of ascending and descending 
colon, in which tissues were exposed to EFS at a frequency 
evoking clear neuronally mediated changes in muscle contrac-
tility. In adult colon from both regions EFS usually caused 
contraction, followed by ‘after-contraction’ on termination of the 
stimulus. The contraction during EFS was cholinergically medi-
ated, attenuated by simultaneous inhibitory nitrergic activa-
tion, their dominance being consistent with greater numbers 
of myenteric neurons in human colon staining for ChAT or 
nNOS.25 However, in the elderly, EFS was increasingly likely 
to evoke muscle relaxation in ascending colon. This difference 
Table 4 Summary of ganglia and cell bodies stained by antibodies 
for HuC/D, ChAT and nNOS per millimetre myenteric plexus in different 
regions of colon from patients of different age groups
Numbers 
per mm of 
myenteric 
plexus
Age group and region of colon
(n=patients studied)
Adult 
ascending
(8)
elderly 
ascending
(9)
Adult 
descending
(9)
elderly 
descending
(10)
HuC/D ganglia/
mm
1.4±0.1 1.7±0.2 2.1±0.2* 2.0±0.1
HuC/D neurons/
mm
7.0±0.9 10.2±0.9 22.9 ± 5.5*† 15.7±1.5
ChAT neurons/
mm
2.4±0.3 5.0±0.6‡ 5.2±0.8§ 4.9±0.8
nNOS neurons/
mm
3.8±0.4 5.3±0.8 6.6±0.8 6.2±0.8
The data are expressed as means±SEM. Differences between the two age groups 
and regions of colon were analysed using analysis of variance with Sidak’s multiple 
comparison tests.
*P<0.01 (between regions).
†Note the existence of an outlier observation among the HuC/D measurements 
(neurons/mm) in adult descending colon, which could not be excluded (see 
figure 3).
‡P<0.05 (between age groups).
§P<0.05 (between regions).
ChAT, choline acetyltransferase; HuC/D, human neuronal protein C/D; nNOS, 
neuronal nitric oxide synthase.
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Figure 4 Density of neuronal innervation within muscle layers. Panel A shows representative examples from protein gene product 9.5 (PGP9.5) 
stained paraffin-embedded sections of human colon muscle. Images were captured using NDP View version 2.3.1. Densiometric analysis was 
performed on filtered images converted to black and white, and the percentage density of staining measured over 400×400 pixel excerpts, as shown 
in the boxes, from the circular muscle (CM) near the myenteric plexus (MP), the deeper CM and the longitudinal muscle (LM), on a fixed magnification 
of 10×, using ImageJ. For each patient, four sections were analysed and for each region of muscle, two different fields were examined in each of the 
four sections by two separate assessors. Panel B shows the density of PGP9.5-positive nerve fibres in the adult (35–60 years of age; □) and elderly 
(≥70 years; ■) groups within ascending and descending colon, n=7 adult and n=8 elderly ascending colon and, respectively, 10 and 9 adult and 
elderly descending colon. Both assessors identified the same statistically significant changes or trends in the elderly (online supplementary data file 
1). These data are expressed as means±SEM and were analysed using analysis of variance with Sidak’s multiple comparison test, *P<0.05; **P<0.01.
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was largely uninfluenced by concurrent disease or medications, 
systematically analysed (unlike previous studies) as potentially 
confounding covariates. Thus, although it remains a possibility 
that other factors not measured could have influenced the data 
(eg, poor glycaemic control, inclusion of premenopausal/post-
menopausal women among the younger group, asymptomatic 
diverticulosis), it seems reasonable to conclude that the data 
support an age-dependent change in neuromuscular functions in 
ascending but surprisingly not in descending colon.
Additional substudies were conducted to determine the mech-
anisms of change in the same cohort of patients. First, we looked 
for changes in numbers and phenotype of myenteric neurons. 
Counting of neurons requires strict application of defined 
criteria,18 performed blind to subject status. In this study, 30 306 
myenteric neurons were counted in 36 patients; anti-HuC/D and 
anti-PGP9.5 assessed, respectively, myenteric ganglia/neuron cell 
bodies and density of nerves within the muscle. This represents 
the largest quantitative measurement of ENS neurons so far 
reported.26 The results indicated that descending colon had 
greater numbers of myenteric neuron cell bodies, and density 
of PGP9.5 staining within the muscle, compared with ascending 
colon (consistent with previous studies26), and increasing age did 
not change these numbers. However, others reported a decline 
in numbers of myenteric ganglia and neurons in elderly human 
colon27 and small intestine.28 The relatively small numbers of 
tissues studied and different staining techniques may explain this 
difference. In the largest previous study, Bernard et al14 found a 
decline in numbers of myenteric neuron cell bodies in descending 
and sigmoid colon staining for HuC/D, ChAT and PGP9.5, but 
no change in numbers of cell bodies staining for nNOS. Here, 
the different findings may be attributed to differences in method 
(whole mount vs paraffin sections) and/or presentation of data. 
In our study, we compared two age groups. Bernard et al tested 
for linear trends, with most patients showing similar numbers of 
HuC/D-staining neurons. In spite of the decline in neuron cell 
bodies, these authors found no age-dependent changes in density 
of PGP9.5 staining of intramuscular axon bundles.
In the present study, there were relatively more nNOS-staining 
neurons within ascending colon (confirming others25), but no 
age-related changes in ascending or descending colon. These 
data are consistent with the suggestion that enteric nitrergic 
neurons do not exhibit age-related loss.6 29 In unspecified regions 
of colon from patients of advanced age, others report higher 
percentage of nitrergic neurons with no changes in numbers of 
calretinin-expressing neurons.16
The present study indicates that ChAT is found in ~30% of 
myenteric neurons within human colon (others suggest 41%–48%25; 
perhaps the difference reflects the quality of antibodies used and 
the counting criteria). A surprising finding was that in ascending, 
not descending colon, the numbers of nerve cell bodies detected 
by anti-ChAT increased in the elderly, seemingly contrasting with 
a generally held view that in rodents, enteric cholinergic neurons 
Table 5 The expression and function of choline acetyltransferase, acetylcholinesterase and butyrylcholinesterase
Age group Ascending Descending region comparison (adult)
Choline acetyltransferase (ChAT) 
  ChAT function (pmol/min/mg) 35–60 years 687±65 (8) 567±83 (10) P value=0.64
≥70 years 688±76 (10) 890±71 (10)
Age comparison P value=1.00 P value=0.01
  ChAT expression (ng/mg) 35–60 years 12.1±2.0 (8) 9.0±0.9 (9) P value=0.27
≥70 years 12.2±1.1 (10) 10.1±0.9 (10)
Age comparison P value=1.00 P value=0.90
  ChAT specific activity (pmol/
ng/min)
35–60 years 67±11 (8) 67±13 (9) P value=1.00
≥70 years 63±10 (10) 97±12 (10)
Age comparison P value=1.00 P value=0.21
Acetyl cholinesterase (AChE) 
  AChE function (nmol/min/mg) 35–60 years 1045±379 (7) 700±132 (8) P value =0.65
≥70 years 451±160 (8) 590±196 (7)
Age comparison P value=0.21 P value=0.98
  AChE expression (ng/mg) 35–60 years 3.8±1.0 (8) 3.1±0.5 (8) P value=0.89
≥70 years 2.7±0.6 (10) 2.3±0.5 (10)
Age comparison P value=0.63 P value=0.80
  AChE specific activity (nmol/
min/mg)
35–60 years 221±46 (7) 251±20 (7) P value=0.96
≥70 years 199±66 (8) 207±37 (7)
Age comparison P value=0.98 P value=0.89
Butryl cholinesterase (BChE) 
  BChE function (nmol/min/mg) 35–60 years 967±295 (7) 620±103 (10) P value =0.42
≥70 years 796±197 (9) 556±75 (10)
Age comparison P value=0.87 P value=0.99
  BChE expression (ng/mg) 35–60 years 573±140 (8) 325±84 (10) P value=0.16
≥70 years 352±70 (10) 292±45 (10)
Age comparison P value=0.24 P value=0.99
  BChE-specific activity (nmol/
min/mg)
35–60 years 1.9±0.4 (7) 3.2±0.8 (10) P value=0.50
≥70 years 2.2±0.4 (9) 2.6±0.7 (10)
Age comparison P value=0.99 P value=0.89
Assays were performed in muscle biopsies taken from patients undergoing resections of the ascending or descending colon. The n values are in parenthesis.
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Figure 5 Age-dependent changes in cholinergic and nitrergic responses to electrical field stimulation (EFS) in human ascending and descending 
colon. EFS was applied at 5 Hz and at 50 V for 10 s every 1 min, in the absence and presence of N
ω
-nitro-L-arginine methyl ester hydrochloride 
(L-NAME) 300 µM or atropine 1 µM. Panels A and D show examples of original traces showing the effects of, respectively, L-NAME and atropine in the 
adult and elderly ascending colon. Similarly, panels B and E show examples of original traces for both treatments in the adult and elderly descending 
colon. Panels C and F show the data for each treatment in each region of adult (35–60 years of age; □) and elderly (≥70 years; ■) colon, for each 
tissue tested. The data are expressed as g tension/g wet weight of tissue, generated during and after termination of EFS, together with the mean±SEM 
contractile force. Respectively, n=14/6 and 7/4 (response generated during/after termination of EFS in the presence of L-NAME and atropine for adult 
ascending colon), 25/6 and 14/6 (elderly ascending colon), 16/8 and 14/8 (adult descending colon) and 23/5 and 15/5 (elderly descending colon); note 
that after-contractions did not always occur so their n values are smaller than for the responses measured during EFS. These were analysed using 
analysis of variance with Sidak’s multiple comparison tests; *P<0.05 only where indicated.
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are lost with increasing age.6 Further experiments, in which ChAT, 
AChE and BChE were extracted from human colon, showed no 
consistent age-dependent differences in overall expression, specific 
activity or function. Similarly in rat colon, cholinesterase activities 
were unchanged by advancing age.30 Thus, these data, together 
with unchanged myenteric neuron cell bodies numbers, may be 
explained not by increased synthesis of ChAT, but by its increased 
presence within cell bodies of existing neurons. ChAT is synthesised 
in the soma of cholinergic neurons and transported to the terminals 
for ACh synthesis.31 In age-related neurodegeneration, impaired 
axonal transport and/or axonal dysfunction are among the earliest 
changes.30–33 Similarly, in mice exposed to the neurotoxic agent 
5-fluorouracil, a decline in numbers of enteric ChAT-immunore-
active and other neurons was preceded by increased number of 
ChAT-immunoreactive neurons.34 In the present experiments, the 
increased detection of ChAT-immunoreactive cell bodies may there-
fore reflect reduced axonal transport of the enzyme away from the 
cell body following age-related damage to axonal transport. Exper-
iments are required to test this hypothesis. The relatively poor 
signal-to-background for the ChAT antibody precludes meaningful 
analysis of ChAT expression by nerve terminals within the muscle, 
but perhaps choline uptake/ACh release could be measured during 
nerve stimulation in human colon.
In the first of additional functional studies, cholinergic and 
nitrergic functions were isolated by, respectively, L-NAME and 
atropine. During the presence of L-NAME, cholinergically medi-
ated contractions evoked by EFS in ascending colon from the 
elderly were smaller compared with adults. A similar difference 
was not observed in descending colon. In the presence of atro-
pine, nitrergically mediated relaxations were not changed with 
increasing age in either region of colon. These data suggest that 
the age-related changes in function observed in the larger func-
tional study (see above) were due to region-dependent decline in 
cholinergic function, which in ascending colon enabled an intact 
nitrergic function to become dominant. This change was not 
due to reduced ability of the muscle to contract (in response to 
carbachol or Bay-K8644, also refuting the possibility of compen-
satory age-dependent changes in muscarinic receptor density35) or 
relax (in response to SNP). Others15 reported a greater maximal 
response to carbachol in sigmoid colon from females, compared 
with males (~60 years), with elderly females (mid-late 70s) being 
more sensitive; by contrast, EFS-evoked contractions and the effect 
of L-NAME on these responses were greater in elderly males. 
However, several muscle strips were used from the same patient, 
n values representing numbers of preparations, not patients; the 
potential for unintentional bias is therefore high. The present data 
also contrast with a reported age-dependent increase in ability 
of human colon muscle cells to contract in response to different 
ligands, including carbachol36; perhaps enzyme digestion influ-
ences how cells respond.
In summary, the size and design of the study aimed to accept, 
control and understand state and trait variability. The data (1) 
represent the most complete set of normative data for the human 
ENS (a recent systematic review identified marked diversity in 
quantification of human ENS markers among numerous small 
studies26), (2) refute previous observations with smaller numbers 
of patients, notably the existence of age-related changes in 
muscle function15 and in neuron numbers within the colon,16 
(3) pose a new hypothesis meriting further study, namely that a 
region-dependent decline in cholinergic functions could be asso-
ciated with increased somal ChAT staining caused by reduced 
axonal transport and (4) indicate that findings from laboratory 
animals do not always translate to humans, species-dependent 
variability35 37 38 being additionally hampered by gross differ-
ences in lower bowel anatomy13 and failure to consider that 
different bowel regions may age differently. Several questions 
remain unanswered. What causes the loss of cholinergic function 
and why only in ascending colon? Possible mechanisms include 
age-related intestinal inflammation,39 susceptibility to reactive 
oxygen species and loss of trophic support from glial cells.40 
In the present study, there was no age-associated difference in 
gross inflammatory status, but more sensitive measurements are 
needed (eg, assessment of age-dependent changes in ‘proinflam-
matory’ status of macrophages41 and analysis of immune activity 
of dendritic cell subsets in different regions of human colon42). 
Interestingly, the high content of living bacteria in ascending 
colon may change in composition among the elderly, promoting 
low-grade inflammation (inflammaging)43 and increasing 
Table 6 Contractions and relaxations of the muscle in adult (35–60 years of age) and elderly (≥70 years) human ascending and descending colon
Ascending Descending
Adult elderly Adult elderly
Compounds causing muscle contraction*
  Carbachol
  0.001–10 µM
pEC50=6.5±0.5
Emax=50±10 g/g
n=7
pEC50=6.2±0.3
Emax=43±6 g/g
n=8
pEC50=6.4±0.2
Emax=53±5 g/g
n=7
pEC50=7.0±0.4
Emax=45±6 g/g
n=12
  Bay-K8644 1 µM
  (in presence of L-NAME 300 µM)
16±7 g/g
n=5
17±8 g/g
n=5
25±9 g/g
n=5
13±3 g/g
n=5
Compound causing muscle relaxation
  SNP†
  0.01–1000 µM
pEC50=6.5±0.8
Emax=1.7±0.2 g/g
n=7
pEC50=6.4±0.6
Emax=1.9±0.2 g/g
n=10
‡ ‡ 
Data are expressed as mean±SEM muscle tension/g of tissue (when using the single concentration of Bay-K8644) or when concentration–response curves were constructed, as 
the pEC50 and Emax values derived from these curves (see online supplementary file 3 for carbachol concentration–response curves in female/male, adult/elderly ascending and 
descending colon). There were no statistically significant differences between values obtained using adult ascending and descending colon or when these values were compared 
with the elderly (p>0.10 each).
*For comparison, in adult ascending and descending colon in the presence of L-NAME 300 µM, EFS generated, respectively, 4.1±1.1 and 2.1±0.5 g tension/g, approximately 
equivalent to the contraction evoked by, respectively, 60 and 4 nM carbachol (~EC7 and EC4 values).
†The effects of SNP were uninfluenced by breakdown in the presence of haemoglobin to form cyanide and methaemoglobin in addition to NO (each can affect tissue viability)—
thus, the magnitude of relaxation evoked by SNP 100 µM in ascending colon was not different to that evoked by the NO donor, diethylamine NONOate 10 µM (respectively, 
1.3±0.5 and 1.4±0.4 g/g, n=6 each, p>0.8).
‡Consistent, concentration-dependent relaxations could not be obtained in descending colon.
EFS, electrical field stimulation; L-NAME, N
ω
 -nitro-L-arginine methyl ester hydrochloride; NO, nitric oxide; SNP, sodium nitroprusside.
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mucosal permeability to allow potentially damaging substances 
to penetrate into the wall of ascending colon. Precedents for 
age-related, region-specific reductions in cholinergic functions 
(and increased ChAT; see Discussion above) exist in brain of 
patients with mild cognitive impairment44 45 and in aged rats.46
Notably, none of the patients studied had previous clinical diag-
nosis of constipation (any history of self-reporting constipation 
was not obtained). It is, therefore, not possible to conclude that 
declined myenteric cholinergic function within the ascending colon 
necessarily leads to clinical constipation. Indeed, other degenera-
tive changes are suggested to contribute to age-related constipa-
tion (including changes in inhibitory junction potentials within the 
descending colon ENS,47 enteric sensory5 and extrinsic sensory 
innervations48). Nevertheless, the reduced cholinergic function 
does support the view that the ENS reserve capacity is reduced in 
the elderly, increasing sensitivity to lifestyle changes affecting intes-
tinal functions (eg, diet, exercise, medications; see the Introduction 
section) and raising the probability of developing constipation. A 
similar argument has been suggested for cholinergic function in 
the aged brain, in which the consequence of a gradual decline in 
synthesis and/or release of ACh from synaptosomes49 only becomes 
apparent when nerves are stressed or damaged.31
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